ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
· the rosen law firm pa
AI Briefing
- Ultragenyx Pharmaceutical Inc. investors reminded of securities class action deadline.
- Purchasers of RARE stock must secure counsel by April 6, 2026.
- Rosen Law Firm is investigating potential claims against the company.
Advertisement